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Abstract
Objective: The main objective of this study was to comparatively evaluate the performance of M.I.C.E. and Etest
methodologies to that of agar dilution for determining the antimicrobial susceptibility profile of oxacillin-resistant
Staphylococcus spp.
Methods: A total of 100 oxacillin-resistant Staphylococcus spp. isolates were collected from hospitalized patients at a
teaching hospital. Antimicrobial susceptibility testing for vancomycin, teicoplanin and linezolid was performed using the
reference CLSI agar dilution method (2009), Etest and M.I.C.E. methodologies. The MIC values were interpreted according to
CLSI susceptibility breakpoints and compared by regression analysis.
Results: In general, the essential agreement (61-log2) between M.I.C.E. and CLSI agar dilution was 93.0%, 84.0% and 77.0%
for linezolid, teicoplanin and vancomycin, respectively. Essential agreement rates between M.I.C.E. and Etest were excellent
(.90.0%) for all antibiotics tested. Both strips (M.I.C.E. and Etest) yielded two very major errors for linezolid. Unacceptable
minor rates were observed for teicoplanin against CoNS and for vancomycin against S. aureus.
Conclusions: According to our results, linezolid and teicoplanin MICs against all staphylococci and S. aureus, respectively,
were more accurately predicted by M.I.C.E. strips. However, the Etest showed better performance than M.I.C.E. for predicting
vancomycin MICs against all staphylococci. Thus, microbiologists must be aware of the different performance of
commercially available gradient strips against staphylococci.
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Introduction
Determination of vancomycin minimum inhibitory concentra-
tion (MIC) has been of crucial importance to guide antimicrobial
therapy against staphylococcal infections since intermediate
resistance to vancomycin has not been accurately detected by
disc diffusion [1]. In addition, treatment failures have been
reported when vancomycin is prescribed for treatment of oxacillin-
resistant Staphylococcus aureus (ORSA) infections, especially for
strains exhibiting vancomycin MICs, $ 2 mg/mL. Studies have
suggested that vancomycin treatment success rates are indirectly
proportional to vancomycin MICs, i.e., vancomycin treatment
success decreases as the MIC of the ORSA strains increases [2]. In
this manner, alternative therapeutic drugs such as linezolid have
been considered for treatment of ORSA infections. Linezolid has
activity against clinically significant gram-positive cocci, including
ORSA and coagulase-negative Staphylococcus (CoNS). The Clinical
Laboratory Standards Institute (CLSI) document M100-S22 [3]
recommends the determination of the linezolid MIC for isolates
categorized as non-susceptible by disc-diffusion methodology.
Therefore, the Oxoid M.I.C.EvaluatorTM (M.I.C.E.) (Thermo
Fisher Scientific, Basingstoke, UK) methodology represents a rapid
alternative for determining vancomycin and linezolid MICs.
In a previous study, we had compared the vancomycin MICs
determined by M.I.C.E. with those obtained by CLSI broth
microdilution (BMD) and observed that the vancomycin MICs
values determined by M.I.C.E. were higher than those obtained
by BMD [4]. A similar finding was latter reported by Rennie et al.
[5]. We thought these results could have resulted from the different
techniques, gradient agar diffusion vs. BMD, employed. The
clinical relevance of determining vancomycin MIC by a reliable
technique motivated us to perform the current study, where the
performance of M.I.C.E. was comparatively evaluated with those
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of CLSI agar dilution and Etest (AB bioMe´rieux, Marcy l’E´toile,
France).
Materials and Methods
Ethical Statement
Ethical approval was not required because the study was
conducted as part of surveillance control management. Written
informed consent was not required because patients received
routine clinical care, and there were no additional specimens
collected or study-specific interventions. Patient records/informa-
tion was anonymized and de-identified prior to analysis.
Bacterial Strains
A total of 100 clinical oxacillin-resistant Staphylococcus spp.
isolates (50 S. aureus and 50 coagulase-negative staphylococci;
CoNS) were collected from hospitalized patients at a Brazilian
teaching hospital located in the city of Sa˜o Paulo. All bacterial
isolates were recovered from blood culture. Only a single isolate
per patient was evaluated. S. haemolyticus (58%) was the most
frequent specie among CoNS, followed by S. hominis (30%) and S.
epidermidis (12%). No Staphylococcus lugdunensis isolate was identified
in this collection. Confirmation of species identification was
performed by MALDI-TOF mass spectrometry (Bruker Daltonics,
Bremen, Germany) after confirming that the cultures were pure
and possessed identical colony morphologies.
Antimicrobial Susceptibility Testing (AST)
AST was performed against vancomycin, teicoplanin and
linezolid by M.I.C.E., Etest (gradient methods), and agar dilution
(reference method) according to CLSI guidelines or respective
manufacturers [3,6]. Antimicrobial powders were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The Etest and M.I.C.E.
MICs were determined as the value at which the elliptical growth
margin intersected the strips, except for linezolid. For this
antimicrobial agent, different manufacturer’s recommendations
have been established for MIC reading, i.e. 90% vs. 80% of the
growth inhibition by Etest and M.I.C.E., respectively. MICs were
rounded up to the next higher twofold dilution for comparison
purposes. Quality control of susceptibility testing was performed
by testing S. aureus ATCC 29213 and Enterococcus faecium ATCC
29212 with results within the CLSI expected ranges for all
antimicrobials and AST methods tested. The MICs were read by
three independent observers with no discordant MICs readings.
Statistical Analysis
The results of the MICs obtained by agar dilution, Etest and
M.I.C.E. techniques were analyzed and compared by regression
analysis using the Statistical Package for the Social Sciences,
version 17.0 (SPSS Inc., Chicago, IL).
Essential agreement was defined when the result of the MICs
obtained by Etest or M.I.C.E. ranged 61-log2 dilution of those
obtained by agar dilution (reference method). Differences of $2-
log2 dilutions were considered as discordant results. Categorical
agreement was defined as test results within the same susceptibility
Table 1. Essential and categorical agreement rates between gradient diffusion tests (M.I.C.E. and Etest) against Staphylococcus
spp.
Diffusion Test M.I.C.E. Etest
Essential Categorical Essential Categorical
Vancomycin
S. aureus 66.0% 68.0% 92.0% 98.0%
S. epidermidis 83% 100,0% 100% 83%
S. haemolythicus 90% 97,0% 97% 97%
S. hominis 87% 100,0% 100% 93%
CoNS 88.0% 98.0% 98.0% 94.0%
Generala 77.0% 83.0% 95.0% 96.0%
Teicoplanin
S. aureus 88.0% 100% 82.0% 100%
S. epidermidis 100% 100% 100% 83%
S. haemolythicus 76% 66% 72% 72%
S. hominis 80% 80% 67% 80%
CoNS 80.0% 74.0% 74.0% 76.0%
Generala 84.0% 87.0% 78.0% 88.0%
Linezolid
S. aureus 98.0% 96.0% 66.0% 96.0%
S. epidermidis 100% 100% 83% 100%
S. haemolythicus 90% 100% 72% 100%
S. hominis 80% 100% 47% 100%
CoNS 88.0% 100% 66.0% 100%
Generala 93.0% 98.0% 66.0% 98.0%
a. S. aureus and CoNS species.
doi:10.1371/journal.pone.0094627.t001
M.I.C.E. Versus Oxacillin-Resistant Staphylococci
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category. Errors were ranked as follows: very major errors, false
susceptible results by gradient methods; major errors, false
resistant results produced by gradient methods; and minor errors,
intermediate by reference method and susceptible or resistant by
the gradient methods or intermediate by the gradient methods and
susceptible or resistant by the reference method. Acceptable error
levels were #1.5% for very major errors, #3% for major errors
and 10% for minor errors as recommended [7].
Results
In comparison to agar dilution, M.I.C.E. methodology yielded
essential and categorical agreement rates of 77.0%/83.0%,
84.0%/87.0%, and 93.0%/98.0% for vancomycin, teicoplanin,
and linezolid, respectively. When these rates were analyzed
according to the staphylococcal species, lower essential and
categorical agreement vancomycin rates were observed for S.
aureus than CoNS isolates (66.0%/68.0% and 88.0%/98.0%,
respectively), as shown in Table 1. In contrast, for teicoplanin,
lower essential and categorical agreement rates were observed for
CoNS (80.0%/74.0%) than S. aureus (88.0%/100%). When testing
linezolid, a variation in the essential and categorical agreement
rates was also observed according to staphylococcal species
(98.0%/96.0% and 88.0%/100% for S. aureus and CoNS,
respectively). Essential and categorical agreement rates for
teicoplanin against CoNS varied according to CoNS species.
These rates were lower for S. haemolythicus than those observed for
S. epidermidis and S. hominis. Most discordant results led to
occurrence of minor errors (16.0% and 12.0% for vancomycin
and teicoplanin against S. aureus and CoNS, respectively). One
(2.0%) major error and two (4.0%) very major errors were
observed for vancomycin and linezolid against S. aureus, respec-
tively.
The essential and categorical agreement rates obtained by Etest
compared to agar dilution were 95.0%/96.0%, 78.0%/88.0%,
and 66.0%/98.0% for vancomycin, teicoplanin, and linezolid,
respectively. A trend for lower linezolid MICs was observed with
Etest against both species analyzed. According to staphylococcal
species no significant variation in the essential and categorical
agreement rates were observed for vancomycin (92.0%/98.0%
and 98.0%/94.0% for S. aureus and CoNS, respectively). However,
lower essential and categorical agreement rates were observed for
CoNS (74.0%/76.0%) than S. aureus (82.0%/100%) for teicopla-
nin. The majority of discordant results led to occurrence of minor
errors (11.0% and 6.0% for teicoplanin and vancomycin,
respectively). One (2.0%) major error against CoNS and two
(4.0%) very major errors against S. aureus were observed for
teicoplanin and linezolid, respectively.
An excellent concordance was observed between M.I.C.E. and
Etest MIC results, which yielded essential agreement rates of
94.0%, 100.0% and 93.0% for vancomycin, teicoplanin, and
linezolid, respectively. However, an unacceptable minor error rate
(18.0%) was detected for vancomycin due to a trend of even higher
MIC values by M.I.C.E. strips.
Discussion
We observed a trend for higher vancomycin MICs for both
strips, Etest and M.I.C.E. This finding is corroborated by previous
studies performed under CLSI recommendations independent of
methodology tested, BMD or agar dilution [4,5]. In general,
vancomycin MICs determined by M.I.C.E. showed a 1-log2
dilution higher than those of Etest [4,5]. It is important to notice
that vancomycin CLSI susceptibility breakpoints for S. aureus (#
2 mg/mL) are 1-log2 dilution lower than those of CoNS (#4 mg/
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mL). It could be one of the reasons for the better performance of
M.I.C.E. strips against CoNS.
To the best of our knowledge, only five studies evaluating
M.I.C.E. methodology have been published to date [4,5,8–10].
Only three of them evaluated Staphylococcus spp., as shown in
Table 2. Our results are in agreement with those studies already
published, except for those published by Mushtaq et al. [8]. These
distinct findings could be due to the medium employed for AST,
since Mushtaq et al. [8] tested Iso-Sensitest agar according to the
British Society for Antimicrobial Chemotherapy (BSAC) guide-
lines. The distinct set of Staphylococcus isolates tested could also have
contributed to the different results.
The present study was the only one to evaluate the performance
of M.I.C.E. for testing teicoplanin against Staphylococcus spp.
Despite of not observing a trend for higher teicoplanin MIC
values, the categorical agreement for both strips (M.I.C.E. and
Etest) compared to agar dilution against CoNS was lower than
80%. When the M.I.C.E. results for teicoplanin against CoNS
were evaluated, the categorical agreement rate (74.0%) remained
lower than that of essential agreement (80.0%). The breakpoints
for interpreting the category of susceptibility to teicoplanin against
CoNS vary between CLSI (susceptible # 8 mg/mL; resistant $
32 mg/mL) and EUCAST (susceptible # 4 mg/mL; resistant .
4 mg/mL). This fact could justify the high rates of minor (24.0%)
and major errors (14.0%) obtained by interpreting this compound
by these respective guidelines, and reemphasize the need for
revision of the current teicoplanin breakpoints against CoNS.
Different results have been reported for linezolid by different
authors. It might be due to the use of distinct reading criteria (80%
vs 90% of growth inhibition for M.I.C.E. and Etest, respectively).
In the present study, a trend for lower linezolid MICs was noticed
for Etest, in agreement with a previous report [5]. In general,
linezolid MICs determined by Etest showed a 1-log2 dilution
higher than those of agar dilution; however, this trend did not
result in changes in the categorization of the isolates.
If M.I.C.E. results were interpreted according to the European
Committee on Antimicrobial Susceptibility Testing (EUCAST)
[11] breakpoints, no variation in the categorical agreement rates
would be observed for vancomycin and linezolid against S. aureus
and CoNS, as shown in Table 3. However, the categorical
agreement rate for teicoplanin against S. aureus would drop from
100% to 68.0%, while it would increase from 74.0% to 80.0%
against CoNS. In addition, by applying the EUCAST breakpoints,
the error rates would be unacceptable for vancomycin and
teicoplanin against S. aureus and for teicoplanin against CoNS.
These different rates could be consequent to the absence of an
intermediate category by EUCAST.
According to our results, linezolid and teicoplanin MICs against
all staphylococci and S. aureus, respectively, were more accurately
predicted by M.I.C.E. strips. However, the Etest showed better
performance than M.I.C.E. for predicting vancomycin MICs
against all staphylococci. Thus, microbiologists must be aware of
the different performance of commercially available gradient strips
against staphylococci.
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